Facts about C***d
https://www.lewrockwell.com/2022/05/no_author/facts-about-c***d/ Fully referenced facts about c***d, provided by experts in the field, to help our readers make a realistic risk assessment. (Regular updates below).
“The only means to fight the plague is honesty.” (Albert Camus, 1947)
Overview
Lethality: The overall infection fatality rate (IFR) of the novel c****av***s in the general population (excluding nursing homes) is about 0.1% to 0.5% in most countries, which is most closely comparable to the medium influenza p******cs of 1936, 1957 and 1968.
Age profile: The median age of c***d deaths is over 80 years in most Western countries (78 in the United States) and about 5% of the deceased had no medical preconditions. In many Western countries, about 50% of all c***d deaths occurred in nursing homes.
V*****e protection: C***d v*****es provide a very high, but rapidly declining protection against severe disease. V******tion cannot prevent infection and t***smission. A prior infection generally confers superior immunity compared to v******tion (in part due to mucosal immunity).
V*****e injuries: C***d v******tions can cause severe and fatal v*****e reactions, including cardiovascular, neurological and immunological reactions. Because of this, the risk-benefit ratio of c***d v******tion in healthy children and adults under 40 years of age remains controversial.
Excess mortality: In most countries, the p******c increased mortality by about 5% to 25%. Some of the additional deaths were caused not by c***d, but by indirect effects of the p******c and lockdowns (including an increase in drug overdose deaths).
Symptoms: About 30% of all infected persons show no symptoms. Overall, about 95% of all people develop at most mild or moderate symptoms and do not require hospitalization. Obesity, in particular, is a major risk factor for severe c***d.
Treatment: For people at high risk or high exposure, early or prophylactic treatment is essential to prevent progression of the disease. Numerous studies found that early outpatient treatment of c***d can significantly reduce hospitalizations and deaths.
Long c***d: Up to 10% of symptomatic people experience post-acute or long c***d, i.e. c***d-related symptoms that last several weeks or months. Long c***d may also affect young and previously healthy people whose initial course of disease was rather mild.
T***smission: Indoor aerosols appear to be the main route of t***smission of the c****av***s, while outdoor aerosols, droplets, as well as most object surfaces appear to play a minor role.
Masks: Face masks had no influence on infection rates, which was already known from studies prior to the p******c. Even N95 masks had no influence on infection rates in the general population. Moreover, long-term or improper use of face masks can lead to health issues.